Literature DB >> 33392187

DJ-1 Regulates Microglial Polarization Through P62-Mediated TRAF6/IRF5 Signaling in Cerebral Ischemia-Reperfusion.

Tingting Wang1,2,3, Na Zhao1,2,3, Li Peng1,2,3, Yumei Li1,2,3, Xiaohuan Huang1,2,3, Jin Zhu1,2,3, Yanlin Chen1,2,3, Shanshan Yu1,2,3, Yong Zhao1,2,3.   

Abstract

The polarization of microglia/macrophage, the resident immune cells in the brain, plays an important role in the injury and repair associated with ischemia-reperfusion (I/R). Previous studies have shown that DJ-1 has a protective effect in cerebral I/R. We found that DJ-1 regulates the polarization of microglial cells/macrophages after cerebral I/R and explored the mechanism by which DJ-1 mediates microglial/macrophage polarization in cerebral I/R. Middle cerebral artery occlusion/reperfusion (MCAO/R) and oxygen and glucose deprivation/reoxygenation (OGD/R) models were used to simulate cerebral I/R in vivo and in vitro, respectively. DJ-1 siRNA and the DJ-1-based polypeptide ND13 were used to produce an effect on DJ-1, and the P62-specific inhibitor XRK3F2 was used to block the effect of P62. Enhancing the expression of DJ-1 induced anti-inflammatory (M2) polarization of microglia/macrophage, and the expression of the anti-inflammatory factors IL-10 and IL-4 increased. Interference with DJ-1 expression induced pro-inflammatory (M1) polarization of microglia/macrophage, and the expression of the proinflammatory factors TNF-α and IL-1β increased. DJ-1 inhibited the expression of P62, impeded the interaction between P62 and TRAF6, and blocked nuclear entry of IRF5. In subsequent experiments, XRK3F2 synergistically promoted the effect of DJ-1 on microglial/macrophage polarization, further attenuating the interaction between P62 and TRAF6.
Copyright © 2020 Wang, Zhao, Peng, Li, Huang, Zhu, Chen, Yu and Zhao.

Entities:  

Keywords:  DJ-1; ND13; P62; TRAF6-IRF5; XRK3F2; ischemia-reperfusion injury; microglial/macrophage polarization

Year:  2020        PMID: 33392187      PMCID: PMC7773790          DOI: 10.3389/fcell.2020.593890

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  5 in total

1.  Long Non-coding RNA ANRIL Downregulation Alleviates Neuroinflammation in an Ischemia Stroke Model via Modulation of the miR-671-5p/NF-κB Pathway.

Authors:  Ling Deng; Jin Jiang; Sha Chen; Xing Lin; Tianrui Zuo; Qingwen Hu; Yu Wu; Xiaomei Fan; Zhi Dong
Journal:  Neurochem Res       Date:  2022-03-31       Impact factor: 3.996

2.  Dexmedetomidine exerts cerebral protective effects against cerebral ischemic injury by promoting the polarization of M2 microglia via the Nrf2/HO-1/NLRP3 pathway.

Authors:  Ning Wang; Huan Nie; Yueyue Zhang; Huiying Han; Shan Wang; Wenjuan Liu; Kuo Tian
Journal:  Inflamm Res       Date:  2021-11-12       Impact factor: 4.575

3.  Ginkgo biloba leaf extract (EGb-761) elicits neuroprotection against cerebral ischemia/reperfusion injury by enhancement of autophagy flux in neurons in the penumbra.

Authors:  Deng Yihao; Guo Tao; Wu Zhiyuan; Zhao Xiaoming; Dong Lingling; He Hongyun
Journal:  Iran J Basic Med Sci       Date:  2021-08       Impact factor: 2.699

4.  A Primeval Mechanism of Tolerance to Desiccation Based on Glycolic Acid Saves Neurons in Mammals from Ischemia by Reducing Intracellular Calcium-Mediated Excitotoxicity.

Authors:  Alexandra Chovsepian; Daniel Berchtold; Katarzyna Winek; Uta Mamrak; Inés Ramírez Álvarez; Yanina Dening; Dominika Golubczyk; Luis Weitbrecht; Claudia Dames; Marine Aillery; Celia Fernandez-Sanz; Zdzislaw Gajewski; Marianne Dieterich; Miroslaw Janowski; Peter Falkai; Piotr Walczak; Nikolaus Plesnila; Andreas Meisel; Francisco Pan-Montojo
Journal:  Adv Sci (Weinh)       Date:  2021-12-14       Impact factor: 16.806

5.  DJ-1 Alleviates Neuroinflammation and the Related Blood-Spinal Cord Barrier Destruction by Suppressing NLRP3 Inflammasome Activation via SOCS1/Rac1/ROS Pathway in a Rat Model of Traumatic Spinal Cord Injury.

Authors:  Lingxin Cai; Liansheng Gao; Guoqiang Zhang; Hanhai Zeng; Xinyan Wu; Xiaoxiao Tan; Cong Qian; Gao Chen
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.